# First Trust Nasdaq Pharmaceuticals ETF (FTXH) — Overview

FTXH · NASDAQ · Fund

Canonical page: https://www.lighthorse.io/tickers/ftxh

## Price

Last close $41.97 on Oct 15, 2026. 52-week range $28.93 – $42.76.

## Fund profile

FTXH tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth.

| Metric | Value |
| --- | --- |
| Issuer | First Trust Advisors L.P. |
| Industry | Healthcare |
| Inception | Sep 20, 2016 |
| Assets under management | $1.1B |
| Expense ratio | 0.60% |
| Net asset value | $41.29 (as of Oct 14, 2026) |
| Distributions | Quarterly |
| Leverage | 1x |

## Frequently Asked Questions

### What is First Trust Nasdaq Pharmaceuticals ETF (FTXH)?

FTXH tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth.

### What is FTXH's expense ratio?

First Trust Nasdaq Pharmaceuticals ETF charges an annual expense ratio of 0.60%. The fund is issued by First Trust Advisors L.P..

### How large is FTXH?

First Trust Nasdaq Pharmaceuticals ETF manages $1.1B in assets and has traded since Sep 20, 2016.

### How do I buy shares of First Trust Nasdaq Pharmaceuticals ETF (FTXH)?

FTXH trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at [Light Horse Dashboard](https://portal.lighthorse.io), the trading API, or an [AI agent connected over MCP](/instructions/ai/claude). The trade panel on this page places the order once you are signed in.

---

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).